CRCA vs. LINT

Last updated Jun 24, 2026

CRCA (ProShares Ultra CRCL) and LINT (Direxion Daily INTC Bull 2X Shares) are both Leveraged Equities funds. Both are actively managed. At a 0.23 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 0.97%/yr for LINT.

Performance

CRCA vs. LINT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra CRCL (CRCA) and Direxion Daily INTC Bull 2X Shares (LINT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRCA achieves a -50.19% return, which is significantly lower than LINT's 744.89% return.

CRCA

• 1D: -10.71%
• 1M: -58.97%
• YTD: -50.19%
• 6M: -54.34%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

LINT

• 1D: -12.86%
• 1M: 11.99%
• YTD: 744.89%
• 6M: 773.46%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRCA vs. LINT - Yearly Performance Comparison

	2026 (YTD)	2025
CRCA ProShares Ultra CRCL	-50.19%	-2.86%
LINT Direxion Daily INTC Bull 2X Shares	744.89%	5.81%

Correlation

The correlation between CRCA and LINT is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Nov 19, 2025	0.23

Return for Risk

CRCA vs. LINT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Direxion Daily INTC Bull 2X Shares (LINT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

CRCA vs. LINT - Drawdown Comparison

The maximum CRCA drawdown since its inception was -94.31%, which is greater than LINT's maximum drawdown of -49.54%. Use the drawdown chart below to compare losses from any high point for CRCA and LINT.

Drawdown Indicators

	CRCA	LINT	Difference
Max Drawdown Largest peak-to-trough decline	-94.31%	-49.54%	-44.77%
Current Drawdown Current decline from peak	-92.37%	-12.86%	-79.51%
Average Drawdown Average peak-to-trough decline	-71.73%	-20.48%	-51.25%

Volatility

Volatility by Period

	CRCA	LINT	Difference
Volatility (1Y) Calculated over the trailing 1-year period	194.67%	168.83%	+25.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	194.67%	168.83%	+25.84%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	194.67%	168.83%	+25.84%

CRCA vs. LINT - Expense Ratio Comparison

CRCA has a 0.95% expense ratio, which is lower than LINT's 0.97% expense ratio.

Dividends

CRCA vs. LINT - Dividend Comparison

CRCA's dividend yield for the trailing twelve months is around 3.48%, more than LINT's 0.10% yield.

Position	TTM	2025
CRCA ProShares Ultra CRCL	3.48%	1.06%
LINT Direxion Daily INTC Bull 2X Shares	0.10%	0.25%

Frequently Asked Questions

Can I hold both CRCA and LINT in my portfolio?

CRCA and LINT have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CRCA or LINT?

On fees, CRCA is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CRCA or LINT?

CRCA is cheaper with a 0.95% expense ratio, compared with 0.97% for LINT.

Which ETF pays a higher dividend yield, CRCA or LINT?

CRCA has the higher dividend yield at 3.48%, compared with 0.10% for LINT.

What is the main difference between CRCA and LINT?

They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for CRCA and 0.97% for LINT.